EFMC-ISMC 2012
International Organising Committee
Symposium Chairmen
B. CLEMENT (Kiel University, Kiel, Germany)
E. OTTOW (Bayer HealthCare, Berlin, Germany)
Members
K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium)
R. P. CLAUSEN (University of Copenhagen)
E. DIFFERDING (Differding Consulting, Louvain-la-Neuve, Belgium)
R. MOREIRA (University of Lisbon, Lisbon, Portugal)
H. TIMMERMAN (VU University Amsterdam, Oegstgeest, The Netherlands)
Local Organising Committee
Members
K.-H. ALTMANN (ETH Zurich, Zurich, Switzerland)
A. BUSCHAUER (University of Regensburg, Regensburg, Germany)
P. GMEINER (Friedrich Alexander University, Erlangen, Germany)
R. HAAG (Free University Berlin, Berlin, Germany)
M. KALESSE (University of Hannover, Hannover, Germany)
S. LAUFER (University of Tuebingen, Tübingen, Germany)
J. MACK (Boehringer Ingelheim, Biberach an der Riss, Germany)
H. P. MAERKI (F. Hoffmann-La Roche, Basel, Switzerland)
P. H. SEEBERGER (Max Planck Institute of Colloids and Interfaces, Berlin, Germany)
O. SEITZ (Humboldt University Berlin, Berlin, Germany)
H. U. STILZ (Sanofi-Aventis, Malov, Denmark)
R. D. SÜSSMUTH (Technical University Berlin, Berlin, Germany)
H. WALDMANN (Max Planck Institute of Molecular Physiology, Dortmund, Germany)
H. WEINMANN (Bayer Pharma, Berlin, Germany)
International Scientific Committee
Members
M. D. ANDREWS (Pfizer, Sandwich, United Kingdom)
P. ARTURSON (University of Uppsala, Uppsala, Sweden)
S. O. BACHURIN (Institute of Physiologically Active Compounds, Chernogolovka, Russia)
E. BANOGLU (Gazi University, Ankara, Turkey)
M. BRANDS (Bayer AG, Wuppertal, Germany)
T. CARELL (Ludwig-Maximilians-University Munich, Munich, Germany)
N. CARRUTHERS (Johnson & Johnson R&D, San Diego, United States)
G. CRISTALLI (University of Camerino, Camerino, Italy)
F. DA SETTIMO (Università di Pisa, Pisa, Italy)
P. S. DA SILVA (Bial Ltd, S. Mamede do Coronado, Portugal)
A. M. DAVIS (AstraZeneca R&D, Loughborough, United Kingdom)
F. DENONNE (UCB Pharma, Braine-l'Alleud, Belgium)
G. DUBURS (Latvian Institute of Organic synthesis, Riga, Latvia)
G. ECKER (University of Vienna, Vienna, Austria)
P. ETTMAYER (Boehringer Ingelheim, Vienna, Austria)
J. FISCHER (Richter Plc, Budapest, Hungary)
C. GARCIA-ECHEVERRIA (Sanofi, Vitry sur Seine, France)
M. GASIC (Serbian Academy of Sciences and Art, Belgrade, Serbia)
G. GAVIRAGHI (Siena Biotech, Siena, Italy)
E. GILLAM (University Queensland, Brisbane, Australia)
M. HANN (GSK Medicines Research Centre, Stevenage, United Kingdom)
R. HARTMANN (Saarland University, Saarbruecken, Germany)
L. HENNEQUIN (AstraZeneca, Reims, France)
T. HOFFMANN (F. Hoffmann-La Roche, Basel, Switzerland)
U. HOLZGRABE (University of Wuerzburg, Wuerzburg, Germany)
K. KIEC-KONONOWICZ (Jagiellonian University, Krakow, Poland)
G. KLEBE (Philipps-University Marburg, Marburg, Germany)
A. KOUROUNAKIS (University of Athens, Athens, Greece)
J. LAU (Novo Nordisk, Maaloev, Denmark)
B. LESUR (Institut de Recherches Servier, Croissy-Sur-Seine, France)
R. LEURS (VU University Amsterdam, Amsterdam, The Netherlands)
M. L. LOPEZ-RODRIGUEZ (Complutense University of Madrid, Madrid, Spain)
D. MA (Shanghai Institute of Organic Chemistry, Shanghai, China)
I. MALNAR (Galapagos, Zagreb, Croatia)
R. MECHOULAM (Hebrew University, Jerusalem, Israel)
L. MEERPOEL (Janssen R&D, Beerse, Belgium)
R. METTERNICH (F. Hoffmann-La Roche, Basel, Switzerland)
J. MINERS (Flinders University School of Medicine, Bedford Park, Australia)
M. MISSBACH (Novartis, Basel, Switzerland)
C. MÜLLER (University of Bonn, Bonn, Germany)
K. MÜLLER (F. Hoffmann-La Roche, Switzerland)
P. O'NEILL (University of Liverpool, Liverpool, United Kingdom)
D. OLIVER (North-West University, Potchefstroom, South Africa)
R. PELLICCIARI (University of Perugia & EFMC, Corciano, Italy)
L. PETERLIN MASIC (University of Ljubljana, Ljubljana, Slovenia)
D. ROGNAN (CNRS-University of Strasbourg, Illkirch, France)
Y. ROLLAND (Société de Chimie Thérapeutique, Châtenay-Malabry, France)
M. ROWLEY (Merck Research Laboratories, Kriens, Switzerland)
F. SANZ (University Pompeu Fabra, Barcelona, Spain)
G. SCHNEIDER (ETH Zürich, Zurich, Switzerland)
G. SERRA (Udelar, Montevideo, Uruguay)
K. B. SIMONSEN (Lundbeck, Valby, Denmark)
G. TAMAGNAN (Institute for Neurodegenerative Disorders and Molecular NeuroImaging, LLC, New Haven, United States)
B. K. TRIVEDI (Wockhardt R&D, Aurangabad, India)
J. UETRECHT (University of Toronto, Toronto, Canada)
E. WALLEN (University of Helsinki, Helsinki, Finland)
H. WEINSTEIN (Cornell University, New York, United States)
R. WEXLER (DuPont Merck Pharmaceutical Co., Princeton, United States)
J. WÖLFLING (University of Szeged, Szeged, Hungary)
A. YONATH (Weizmann Institute of Science, Rehovot, Israel)
L.-H. ZHANG (Beying Medical University, Beying, China)
M.-Q. ZHANG (Amgen China, Shanghai, China)
<Previous page


SUPPORTED BY

PREMIER SPONSORS

CORPORATE SPONSORS

CLOSING LUNCH SPONSOR

CONTRIBUTORS

AWARD SPONSORS

TRAVEL GRANT SPONSOR

MEDIA PARTNERS